![Translating Evidence of HDL and Plaque Regression | Arteriosclerosis, Thrombosis, and Vascular Biology Translating Evidence of HDL and Plaque Regression | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/ec833a62-4209-4b27-a0de-734c7bbd6ce1/1961fig01.jpg)
Translating Evidence of HDL and Plaque Regression | Arteriosclerosis, Thrombosis, and Vascular Biology
![Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0031942202004454-gr5.gif)
Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect
![Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology](https://molpharm.aspetjournals.org/content/molpharm/82/2/246/F2.large.jpg)
Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology
![Nutrients | Free Full-Text | Extra Virgin Olive Oil Phenol Extracts Exert Hypocholesterolemic Effects through the Modulation of the LDLR Pathway: In Vitro and Cellular Mechanism of Action Elucidation | HTML Nutrients | Free Full-Text | Extra Virgin Olive Oil Phenol Extracts Exert Hypocholesterolemic Effects through the Modulation of the LDLR Pathway: In Vitro and Cellular Mechanism of Action Elucidation | HTML](https://www.mdpi.com/nutrients/nutrients-12-01723/article_deploy/html/images/nutrients-12-01723-ag.png)
Nutrients | Free Full-Text | Extra Virgin Olive Oil Phenol Extracts Exert Hypocholesterolemic Effects through the Modulation of the LDLR Pathway: In Vitro and Cellular Mechanism of Action Elucidation | HTML
![Ioannis ROUSSIS | Research Director | Professor | University of Ioannina, Ioánnina | UOI | Department of Chemistry Ioannis ROUSSIS | Research Director | Professor | University of Ioannina, Ioánnina | UOI | Department of Chemistry](https://www.researchgate.net/profile/Ioannis-Roussis/publication/250143705/figure/tbl1/AS:671519776714780@1537114199401/Inhibition-of-The-Oxidation-of-Corn-Oil-Stripped-of-Tocopherols-A234-nm-A270-nm-and_Q320.jpg)
Ioannis ROUSSIS | Research Director | Professor | University of Ioannina, Ioánnina | UOI | Department of Chemistry
![Nrf2 is essential for cholesterol crystal‐induced inflammasome activation and exacerbation of atherosclerosis - Freigang - 2011 - European Journal of Immunology - Wiley Online Library Nrf2 is essential for cholesterol crystal‐induced inflammasome activation and exacerbation of atherosclerosis - Freigang - 2011 - European Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9b5eb14d-5ced-4519-ad17-2326f5bf6e98/mfig001.jpg)
Nrf2 is essential for cholesterol crystal‐induced inflammasome activation and exacerbation of atherosclerosis - Freigang - 2011 - European Journal of Immunology - Wiley Online Library
![Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000930841830001X-gr8.jpg)
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect
![Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000930841830001X-gr2.jpg)
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect
![Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0031942202004454-fx3.gif)
Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect
![Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000930841830001X-gr4.jpg)
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect
![Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease | Journal of Inflammation | Full Text Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease | Journal of Inflammation | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12950-019-0211-5/MediaObjects/12950_2019_211_Fig4_HTML.png)
Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease | Journal of Inflammation | Full Text
![Inhibition of LDL oxidation and inflammasome assembly by nitroaliphatic derivatives. Potential use as anti-inflammatory and anti-atherogenic agents - ScienceDirect Inhibition of LDL oxidation and inflammasome assembly by nitroaliphatic derivatives. Potential use as anti-inflammatory and anti-atherogenic agents - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523418308407-gr4.jpg)
Inhibition of LDL oxidation and inflammasome assembly by nitroaliphatic derivatives. Potential use as anti-inflammatory and anti-atherogenic agents - ScienceDirect
![Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology](https://molpharm.aspetjournals.org/content/molpharm/82/2/246/F4.large.jpg)
Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology
![Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000930841830001X-gr1.jpg)
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect
![Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000930841830001X-gr6.jpg)
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed - ScienceDirect
![Oxidized Low-Density Lipoprotein Suppresses Expression of Prostaglandin E Receptor Subtype EP3 in Human THP-1 Macrophages Oxidized Low-Density Lipoprotein Suppresses Expression of Prostaglandin E Receptor Subtype EP3 in Human THP-1 Macrophages](https://ndownloader.figstatic.com/files/1725640/preview/1725640/preview.jpg)
Oxidized Low-Density Lipoprotein Suppresses Expression of Prostaglandin E Receptor Subtype EP3 in Human THP-1 Macrophages
![CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice - Atherosclerosis CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice - Atherosclerosis](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/98c30c04-970d-4a74-a914-855b370e9f79/gr2.jpg)
CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice - Atherosclerosis
![Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0031942202004454-gr4.jpg)
Inhibition of LDL oxidation by flavonoids in relation to their structure and calculated enthalpy - ScienceDirect
![Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption | Molecular Pharmacology](https://molpharm.aspetjournals.org/content/molpharm/82/2/246/F6.large.jpg?width=800&height=600&carousel=1)